Sign in
4

Changes in Ownership

Edesa Biotech, Inc. Filed Acc 0001144204-18-014754

Options or other derivatives

  • Director acquired 2,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Olson Charles V Director 2018-03-12 Grant or award · Share Option (Right to Buy) +2,500 2,500 D
Loading xslF345X03/tv488522_4.xml…